FINANCIAL SUMMARY - FOURTH QUARTER 2020
Qlife extends contract with Divisionsforeningen
In cooperation with KMD, Qlife has extended the contract with Divisionsforeningen. The extended contract is the continuation of COVID-19 testing of players and personnel in the two best football leagues, 3F Superligaen and NordicBet Ligaen, in Denmark. The contract extension is based upon the successful COVID-19 testing that Qlife delivered over the summer and will continue in an adjusted format.
The contract has been adjusted to reflect the lesser infectious rates over the past few months and to equal realistically economic circumstances that the clubs operate under. Among others Qlife will implement an adjusted protocol where samples from up to 5 players are pooled together so that the testing volume becomes lower.
“The extension of our contract with Divisionsforeningen is a confirmation of the quality of our ongoing work at Qlife, and we are happy to be able to offer an adjusted protocol that meet the needs of the clubs and Divisionsforeningen. Together with KMD, we continue to provide testing protocols that provide timely results. The continuation of the project is of significance to us, as it underlines that the organisation is capable of handling a large-scale project despite our limited time of commercial operation and small size.”, says Thomas Warthoe, CEO of Qlife.
“KMD has been able to set up a data platform corresponding to the need of Qlife and Divisionsforeningen that works very well. The handling of data is a crucial component in the COVID-19 testing setup, as it secures safe delivery of test results from Qlife to the football clubs. Going forwards, we will continue to work in close collaboration with Qlife to enhance the data handling processes even further.” – Christian Binggeli-Winter, Director and Head of KMD's Data and Analysis Unit.
“Test of players and other personnel has been crucial for us to start and finish the 19/20 season. The only responsible thing to do now, is to continue with tests in the coming season, to ensure the safety of players, clubs and fans. Together with our thorough protocols it can hopefully be a contributing factor for getting more fans onto the stadiums” – says Claus Thomsen, Director of Divisionsforeningen.
“It is of great importance for Qlife to get a significant order from a highly professional customer directly after the CE-marking.
The Danish Patent Office has granted Qlife patent number DK180348 B1 for its biomarker detection unit.
The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market.
Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short.
Since May 2020, Qlife has been handling all testing for COVID-19 for professional football in Denmark.
On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for temporay approval in Denmark “in the interest of health protection” for th
”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high preci
Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrants